Filter
285
Filtered Results: 285
Text search:
African
Trypanosomiasis
Featured
Recommendations
36
New Publications
54
Language
Document type
No document type
96
Studies & Reports
78
Guidelines
35
Strategic & Response Plan
24
Manuals
23
Resource Platforms
9
Dashboards/Maps
6
Training Material
5
Brochures
3
Situation Updates
2
Fact sheets
2
Infographics
1
Videos
1
Countries / Regions
Global
24
Africa
13
Uganda
13
Congo, Democratic Republic of
10
Liberia
7
West and Central Africa
6
Kenya
5
Ghana
5
Sierra Leone
5
Malawi
5
East and Southern Africa
5
South Africa
4
Zambia
4
South Sudan
4
Benin
3
Burkina Faso
3
Guinea
3
Latin America and the Carribbean
3
Tanzania
3
Central African Republic
3
Chad
3
India
3
Rwanda
2
Cameroon
2
Nigeria
2
Zimbabwe
2
Middle East and North Africa
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Angola
2
Colombia
1
El Salvador
1
Syria
1
Iran
1
Senegal
1
Niger
1
Afghanistan
1
Qatar
1
Asia
1
Jordan
1
Saudi Arabia
1
South–East Asia Region
1
Western and Central Europe
1
Southern Africa
1
Lebanon
1
Djibouti
1
Egypt
1
Sudan
1
Yemen
1
Palestine
1
Mali
1
Libya
1
Botswana
1
Iraq
1
Somalia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
81
Clinical Guidelines
31
Public Health
29
Key Resources
12
Pharmacy & Technologies
9
Capacity Building
8
Women & Child Health
5
Toolboxes
NTDs
119
Rapid Response
18
Planetary Health
13
Pharmacy
8
Ebola & Marburg
6
Caregiver
6
HIV
5
AMR
5
NCDs
4
Mental Health
3
TB
3
COVID-19
3
Conflict
2
Refugee
1
Natural Hazards
1
Disability
1
Cholera
1
Social Ethics
1
Global Health Education
1
Human African trypanosomiasis is caused by Trypanosoma brucei gambiense in West and Central Africa and by T. brucei rhodesiense in East Africa; both species are endemic in Uganda. Trypanosoma brucei gambiense accounts for 98% of all cases of African trypanosomiasis, and T. brucei rhodesiense account...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
More countries eliminate human African trypanosomiasis as a public health problem: Benin and Uganda (gambiense form) and Rwanda (rhodesiense form)
Human African trypanosomiasis (HAT), or sleeping sickness, transmitted by tsetse flies in sub-Saharan Africa, is a life-threatening disease that afflict...
The Lancet Volume 390, Issue 10110p2397-2409November 25, 2017.
Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to death, unless treatment is provided. HAT caused devastating epidemics during the 20th century. Thanks to ...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
MSD Manual Professional Version
MSD Manual Consumer Version
Learning sheet no. 4
Accessed March, 2025
Human African trypanosomiasis (HAT), or sleeping sickness, is caused by trypanosome parasites that are transmitted by tsetse flies. HAT is found only in sub-Saharan Africa. Two subspecies of Trypanosoma brucei cause disease: T. b. gambiense in West and Central Africa, and T. b. rhodesiense in East A...
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face significant difficulties of diverse natures.
Human African trypanosomiasis (HAT) is a lethal neglected tropical disease (NTD) transmitted by the bite of infected tsetse flies. The disease is also known as “sleeping sickness”. During the 20th century it caused enormous suffering in the endemic areas in sub-Saharan Africa. HAT transmission l...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Resource Platform
Chapter in Clinical guidelines -Diagnosis and Treatment manual
PLoS Negl Trop Dis 16(11): e0010885. https://doi.org/10.1371/journal.pntd.0010885
HAT diagnosis in non-endemic countries is rare and can be challenging, but alertness and
surveillance must be maintained to contribute to WHO’s elimination goals. Early detection is
particularly important as it co...
Database with maps and country-specific numbers
